Members of the Utah Rare Disease Advisory Council (RDAC) on…
Read More »
Utah’s life sciences industry left its mark on this week’s…
Premier CNS-Focused Research Facilities in California and New Jersey Join…
The Senate Health, Education, Labor and Pensions (HELP) Committee voted…
HT-6184 is a novel NEK7/NLRP3 inhibitor
BD is among the first companies to enter innovative partnership…
MANCHESTER, England & SALT LAKE CITY–(BUSINESS WIRE)–The University of Manchester,…
CAMBRIDGE, Mass., June 8, 2022 /PRNewswire/ — Sumitomo Pharma Oncology,…
CHICAGO, June 06, 2022 — Elevar Therapeutics, Inc., a fully…
CerTest Biotec Uses the BD MAX™ Molecular Diagnostic System Open…
Expands BD Transformative Solutions to Provide New Pharmacy Automation Technologies…
Data shared in oral presentation at American Diabetes Association 82nd…
PolarityTE announced that it has entered into securities purchase agreements…
Profil has conducted over 30 biosimilar insulin trials and is…
BIOMERICS ANNOUNCES EXPANSION INTO IRELAND Expanding High-Performance Balloon Design &…
Co-Diagnostics announced that it has completed the principal design work…
SALT LAKE CITY, UTAH (Monday, May 2, 2022) – Biomerics,…
Marcy l’Étoile, France – bioMérieux, a world leader in the…
PolarityTE announced that the Company will effectuate a 1-for-25 reverse…
PolarityTE provided a business update and reported financial results for…
Notifications
